Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2021

The year in review of molecularly driven NSCLC 

Opening new horizons: RET, NTRK, MET, HER2… 

Date

16 Sep 2021

Session

The year in review of molecularly driven NSCLC 

Topics

Cytotoxic Therapy;  Clinical Research;  Translational Research

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Herbert Ho Fung Loong

Authors

H.H.F. Loong

Author affiliations

  • Department Of Clinical Oncology, The Chinese University of Hong Kong - Prince of Wales Hospital, Sha Tin/HK

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.